e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Obstructive sleep apnoea in adults and children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ERS Statement: Obstructive sleep-disordered breathing in children 2-18 years old. Risk factors, associated morbidity, predictors of persistent disease and assessment of disease severity
Athanasios G Kaditis (Athens, Greece)
Source:
International Congress 2015 – Obstructive sleep apnoea in adults and children
Session:
Obstructive sleep apnoea in adults and children
Session type:
Session
Number:
442
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Athanasios G Kaditis (Athens, Greece). ERS Statement: Obstructive sleep-disordered breathing in children 2-18 years old. Risk factors, associated morbidity, predictors of persistent disease and assessment of disease severity. International Congress 2015 – Obstructive sleep apnoea in adults and children
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert view on treatment approach to children with persistent obstructive sleep apnoea
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Obstructive sleep-disordered breathing in children 2-18 years old: indications for treatment, stepwise treatment approach and recognition and management of persistent disease
Source: International Congress 2015 – Obstructive sleep apnoea in adults and children
Year: 2015
Differences in prevalence of metabolic syndrome (MS) between male and female patients with moderate and severe obstructive sleep apnea. The definition is certainly an important factor
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Does Nutritional Risk Screening 2002 correlate with dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Impact of obstructive sleep apnea and CPAP treatment on mortality and cardio and cerebrovascular consequences in men of the general population after 20 years of follow-up.
Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Year: 2020
Comorbidity: a distinctive feature of elderly respiratory patients
Source: Eur Respir Mon; 2009: 43: 205–216
Year: 2009
Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
Obstructive sleep apnoea and risk of cardiovascular disease in men. A follow-up study
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003
Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Modifiable risk factors for all-cause hospitalization in obstructive lung disease
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Patients with sleep apnoea(SA) and severe/difficult to treat asthma(SDTA) have worse asthma related clinical outcomes than those with no sleep apnoea
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016
Cycle length identifies complex sleep apnea in patients with chronic heart failure - A matched control study
Source: International Congress 2016 – Central sleep apnoea and the central regulation of obstructive and central sleep apneoa
Year: 2016
Ventilatory function as predictor of cardio-metabolic markers of cardiovascular disease: 10 year follow-up in young adults
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Prevalence of metabolic syndrome (MS) in a population of apneic patients:
A prospective study with cardiovascular risk estimation
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Novel approaches for pulmonary rehabilitation in chronic lung diseases
Year: 2016
Global and regional trends in mortality from chronic obstructive pulmonary disease: Their relation to poverty, smoking and population change
Source: International Congress 2014 – New insights into the epidemiology of COPD
Year: 2014
Cardiovascular morbidity and mortality in patients with obstructive sleep apnea - a prospective study
Source: Annual Congress 2005 - What should we know about our SAS patients
Year: 2005
Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Moderate obstructive sleep apnea and cardiovascular outcomes in elder patients: a propensity score matched, multicentric study (CPAGE-MODE study)
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021
Obstructive sleep apnoea is not a risk factor for incident hospitalised depression: a historical cohort study
Source: Eur Respir J, 49 (6) 1601361; 10.1183/13993003.01361-2016
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept